NCT06614140 2026-04-22Personalized Neoantigen Cancer Vaccine for Patients With Solid TumorsSeqker Biosciences, Inc.Phase 1/2 Completed8 enrolled
NCT06782932 2025-12-03Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic CancerSidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1/2 Recruiting38 enrolled